Trials / NCT05786287
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Not yet recruiting Observational Natural history / observational
- Sponsor
- PT. Prodia Stem Cell Indonesia
- Treatment
- Conditioned Medium (CM); Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 65 Years
- Enrollment
- 18 participants
- Started
- 2026-05
- Main results expected
- 2027-07
- Results posted
- Not yet
- Record last updated
- 2026-02-25
What the study is testing
The study will perform to follow-up UC-MSCs and CM transplantation. 18 patients will be called back to be examined after 5 years of UC-MSC and/or CM transplantation.
Where it runs
Indonesia (2)
- Jakarta Eye Center Hospital, Jakarta, DKI Jakarta
- Sardjito Hospital, Yogyakarta, Special Region